Qinecsa COO, John Cogan, has been featured in European Pharmaceutical Manufacturer‘s latest article, where he discusses AI’s pivotal role in powering the pharmacovigilance engine.
As pharmacovigilance centers on tracking and processing adverse events – a critical aspect of regulatory compliance – leveraging technology to streamline or outsource these demanding processes is more important than ever.
